Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment

Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant treatment in a randomized controlled trial (RCT),...

Descripción completa

Detalles Bibliográficos
Autores principales: Huss, Michael, Sikirica, Vanja, Hervas, Amaia, Newcorn, Jeffrey H, Harpin, Valerie, Robertson, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863687/
https://www.ncbi.nlm.nih.gov/pubmed/27226715
http://dx.doi.org/10.2147/NDT.S94158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863687/
https://www.ncbi.nlm.nih.gov/pubmed/27226715
http://dx.doi.org/10.2147/NDT.S94158

Ejemplares similares